Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug utilisatIon Study of Radium 223 Under Routine Clinical Practice in Europe

NCT04587427 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04587427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04587427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug utilisatIon Study of Radium 223 Under Routine Clinical Practice in Europe
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 15, 2021
Completion date
May 30, 2023
Enrollment
1,067 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastatic castration-resistant prostate cancer